Fresenius Medical Care AG (FMS)
 NYSE: FMS · Real-Time Price · USD
 26.35
 -0.49 (-1.83%)
  At close: Nov 3, 2025, 4:00 PM EST
24.64
 -1.71 (-6.49%)
  Pre-market: Nov 4, 2025, 5:48 AM EST
Fresenius Medical Care AG Market Cap
Fresenius Medical Care AG has a market cap or net worth of $15.24 billion as of November 4, 2025. Its market cap has increased by 29.63% in one year.
Market Cap 
 15.24B
Enterprise Value 
 27.22B
1-Year Change 
 29.63%
Ranking 
 Category 
 Stock Price 
$26.35
Market Cap Chart
Since December 1, 1998, Fresenius Medical Care AG's market cap has increased from $5.99B to $15.24B, an increase of 154.65%. That is a compound annual growth rate of 3.53%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Nov 3, 2025 | 15.46B | 16.39% | 
| Dec 31, 2024 | 13.29B | 8.69% | 
| Dec 29, 2023 | 12.22B | 27.48% | 
| Dec 30, 2022 | 9.59B | -49.57% | 
| Dec 31, 2021 | 19.01B | -23.32% | 
| Dec 31, 2020 | 24.80B | 9.70% | 
| Dec 31, 2019 | 22.60B | 13.87% | 
| Dec 31, 2018 | 19.85B | -38.32% | 
| Dec 29, 2017 | 32.18B | 24.87% | 
| Dec 30, 2016 | 25.77B | 2.18% | 
| Dec 31, 2015 | 25.23B | 12.65% | 
| Dec 31, 2014 | 22.39B | 3.94% | 
| Dec 31, 2013 | 21.54B | 4.62% | 
| Dec 31, 2012 | 20.59B | 1.55% | 
| Dec 30, 2011 | 20.28B | 18.85% | 
| Dec 31, 2010 | 17.06B | 9.93% | 
| Dec 31, 2009 | 15.52B | 12.36% | 
| Dec 31, 2008 | 13.81B | -10.15% | 
| Dec 31, 2007 | 15.37B | 64.77% | 
| Dec 29, 2006 | 9.33B | 131.35% | 
| Dec 31, 2002 | 4.03B | -31.05% | 
| Dec 31, 2001 | 5.85B | -26.55% | 
| Dec 29, 2000 | 7.96B | -4.19% | 
| Dec 31, 1999 | 8.31B | 20.77% | 
| Dec 31, 1998 | 6.88B | 14.97% | 
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 802.74B | 
| Johnson & Johnson | 448.76B | 
| AbbVie | 374.44B | 
| UnitedHealth Group | 302.36B | 
| AstraZeneca | 252.04B | 
| Novartis AG | 236.44B | 
| Novo Nordisk | 216.34B | 
| Abbott Laboratories | 215.34B |